Literature DB >> 18632956

Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice.

Hui-Gang Shen1,2, Ji-Yong Zhou1,2, Zhen-Yu Huang2, Jun-Qing Guo1,2, Gang Xing2, Jia-Ling He2, Yan Yan1,2, Li-Yang Gong1,2.   

Abstract

The protective immune response against porcine circovirus 2 (PCV2) infection in mice was characterized using flow cytometric analysis (FCM), assays of antibody (of different IgG isotypes) and viraemia, and histopathological examination. An open reading frame 2 plasmid (pORF2) and the capsid protein (Cap) of PCV2 were used as DNA and subunit vaccines, respectively. In FCM analysis, although pORF2 and Cap alone showed comparable efficacy in eliciting lymphoproliferative responses and Cap-specific CD4(+) T cells, pORF2 was superior to the Cap protein in triggering CD8(+) T cells. A virus neutralization assay showed that pORF2 evoked stronger recall virus-neutralizing (VN) antibody responses than the Cap protein on PCV2 challenge. Correspondingly, VN antibody kinetics coincided with those of Cap-specific IgG2a, but not with the kinetics of IgG and IgG1. Following virus challenge, real-time PCR and histopathological analysis confirmed that only low viral DNA loads and mild microscopic lesions appeared in pORF2-immunized mice. These findings indicate that CD8(+) T cells and VN antibody responses correlating mainly with Cap-specific IgG2a play crucial roles in protecting against PCV2 infection, and that the protective immunity induced by the pORF2 plasmid is superior to that induced by the PCV2 Cap protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632956     DOI: 10.1099/vir.0.2008/000125-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.

Authors:  Guang-Lei Chen; Peng-Fei Fu; Lin-Qing Wang; Xin-Sheng Li; Hong-Ying Chen
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

2.  Circovirus transport proceeds via direct interaction of the cytoplasmic dynein IC1 subunit with the viral capsid protein.

Authors:  Jingjing Cao; Cui Lin; Huijuan Wang; Lun Wang; Niu Zhou; Yulan Jin; Min Liao; Jiyong Zhou
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

3.  Studies on porcine circovirus type 2 vaccination of 5-day-old piglets.

Authors:  K C O'Neill; H G Shen; K Lin; M Hemann; N M Beach; X J Meng; P G Halbur; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

4.  Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.

Authors:  Changhoon Park; Jiwoon Jeong; Kyuhyung Choi; Su-Jin Park; Ikjae Kang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

5.  Evaluation of the efficacy of a novel porcine circovirus type 2 synthetic peptide vaccine.

Authors:  Jiwoon Jeong; Changhoon Park; Seeun Kim; Su-Jin Park; Ikjae Kang; Kee Hwan Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

6.  Identification and functional analysis of the novel ORF4 protein encoded by porcine circovirus type 2.

Authors:  Jialing He; Jingjing Cao; Niu Zhou; Yulan Jin; Jiusheng Wu; Jiyong Zhou
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

7.  Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice.

Authors:  Chunyan Zhang; Shanshan Zhu; Li Wei; Xu Yan; Jing Wang; Rong Quan; Ruiping She; Fengjiao Hu; Jue Liu
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

8.  Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.

Authors:  Kun Yang; Wentao Li; Huihui Niu; Weidong Yan; Xiaoli Liu; Yang Wang; Shuang Cheng; Xugang Ku; Qigai He
Journal:  Acta Vet Scand       Date:  2012-11-21       Impact factor: 1.695

9.  Antigenic Determinants of Possible Vaccine Escape by Porcine Circovirus Subtype 2b Viruses.

Authors:  Megan Constans; Marvin Ssemadaali; Oleksandr Kolyvushko; Sheela Ramamoorthy
Journal:  Bioinform Biol Insights       Date:  2015-08-23

10.  Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.

Authors:  Shanshan Zhu; Chunyan Zhang; Jing Wang; Li Wei; Rong Quan; Jiayu Yang; Xu Yan; Zixuan Li; Ruiping She; Fengjiao Hu; Jue Liu
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.